SOME BIOCHEMICAL STUDIES ON PSILOCYBIN AND PSILOCIN

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Neuropsychiatry and Clinical Neurosciences

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1176/JNP.4.3.270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Psilocybin and hallucinogenic mushrooms

  2024cites this paper
• Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders

  2023influential citation
• Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology

  2022cites this paper
• Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?

  2021cites this paper
• A potential role for psilocybin in the treatment of obsessive-compulsive disorder

  2020cites this paper
• Psilocybin: from ancient magic to modern medicine

  2020cites this paper
• Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

  2017cites this paper
• Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals

  2016cites this paper
• Dysregulation of tryptophan metabolism in a sub-Saharan HIV/AIDS population

  2015cites this paper
• The kynurenine pathway activities in a sub-Saharan HIV/AIDS population

  2015cites this paper
• Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans

  2015cites this paper
• 14C-Psilocin tissue distribution in pregnant rats after intravenous administration

  2014cites this paper
• C-Psilocin tissue distribution in pregnant rats after intravenous administration

  2014cites this paper
• Medical Disorders and Behavioral Risk Factors

  2014cites this paper
• Heme Oxygenase-1 Dysregulation in the Brain: Implications for HIV-Associated Neurocognitive Disorders

  2014cites this paper
• Psilocybin--summary of knowledge and new perspectives.

  2014cites this paper
• Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol: Analytical Methods and Biologic Activities

  2013cites this paper
• Schizophrenia and major depression as inflammatory CNS disorders

  2012cites this paper
• Factors Associated with Neuropsychological Impairment in HIV Infection

  2011cites this paper
• A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease

  2010cites this paper
• Entzündliche Veränderungen als gemeinsame Pathogenese affektiver und schizophrener Erkrankungen

  2010cites this paper
• Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder

  2010cites this paper
• Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS

  2010cites this paper
• Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation

  2009cites this paper
• The Changing Face of HIV-Associated Cognitive and Neuropsychiatric Disturbance

  2009cites this paper
• Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids

  2009cites this paper
• Involvement of quinolinic acid in aids dementia complex

  2009cites this paper
• Historical overview of psychoactive mushrooms

  2009cites this paper
• A psychoneuroimmunological perspective to Emil Kraepelins dichotomy

  2008cites this paper
• Biomarkers of HIV related central nervous system disease

  2008cites this paper
• Molecular Pathogenesis for Schizophrenia and Major Depression

  2008cites this paper
• The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

  2007cites this paper
• Psilocybin-induced stimulus control in the rat.

  2007cites this paper
• Immunologische Aspekte bei depressiven Störungen

  2007cites this paper
• Enlentecimiento cognitivo en sujetos seropositivos asintomáticos al virus de inmunodeficiencia humana tipo 1

  2006cites this paper
• Neuroimmune–endocrine crosstalk in schizophrenia and mood disorders

  2006cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CIÊNCIAS BÁSICAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS

  2006cites this paper
• Efeito in vitro de quinureninas sobre vários parâmetros de estresse oxidativo em córtex cerebral de ratos jovens

  2006cites this paper
• Efeito da administração intraestriatal aguda de ácido quinolínico sobre metabolismo energético em ratos jovens

  2006cites this paper
• The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis

  2006cites this paper
• Molecular and cellular mechanisms of neuronal cell death in HIV dementia

  2005cites this paper
• Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium.

  2004cites this paper
• Impaired Performance on a Rhesus Monkey Neuropsychological Testing Battery following Simian Immunodeficiency Virus Infection

  2004cites this paper
• HUMANS: An English and Spanish Neuropsychological Test Battery for Assessing HIV-1-Infected Individuals—Initial Report

  2004cites this paper
• Computerized reaction time battery versus a traditional neuropsychological battery: Detecting HIV-related impairments

  2003cites this paper
• Tryptophan Metabolites and Brain Disorders

  2003cites this paper
• Cognitive Functioning in Younger and Older HIV‐1‐Infected Adults

  2003cites this paper
• Influence of depressed mood on neuropsychologic performance in HIV‐seropositive drug users

  2003cites this paper
• Working memory performance predicts subjective cognitive complaints in HIV infection.

  2002cites this paper
• The pharmacology of psilocybin

  2002cites this paper
• A meta-analysis of the neuropsychological sequelae of HIV infection

  2002cites this paper
• Reaction time slowing in adults with HIV: results of a meta-analysis using brinley plots.

  2002cites this paper
• Paradigms for behavioral assessment of viral pathogenesis.

  2001cites this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cites this paper
• Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.

  2001cites this paper
• A global review of legislation on HIV/AIDS: the issue of HIV testing.

  2001cites this paper
• Methylphenidate improves HIV-1-associated cognitive slowing.

  2001cites this paper
• The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines

  2001cites this paper
• Cerebrospinal Fluid 5-Hydroxytryptamine and 5-Hydroxyindoleacetic Acid in HIV-1 Infection

  2001cites this paper
• Endogenous neurotoxins from tryptophan.

  2001cites this paper
• Declining immune function in children and adolescents with hemophilia and HIV infection: effects on neuropsychological performance. Hemophilia Growth and Development Study.

  2000cites this paper
• Cognitive Effects of HIV-1 Infection

  2000cites this paper
• HIV-1 Infection Spectrum Disease

  2000cites this paper
• Computerized and traditional stroop task dysfunction in HIV-1 infection.

  1999cites this paper
• Microglia as mediators of inflammatory and degenerative diseases.

  1999cites this paper
• Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report.

  1999cites this paper
• The role of excitotoxicity in neurodegenerative disease: implications for therapy.

  1999cites this paper
• S-aryl cysteine S,S-dioxides as inhibitors of mammalian kynureninase.

  1998cites this paper
• Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.

  1998cites this paper
• Apathy, depression, and cognitive performance in HIV-1 infection.

  1998cites this paper
• Information processing and antiretroviral therapy in HIV-1 infection

  1998cites this paper
• Neuropsychological performance of HIV-1 infected men with major depression

  1997cites this paper
• Cognitive function in asymptomatic HIV infection.

  1997cites this paper
• The Relationship Between Neuropsychological Functioning and Coping Activity Among HIV-Positive Men

  1997cites this paper
• Neuropsychological Dysfunction in HIV Infection:A Review.

  1996cites this paper
• Methodological issues in the study of HIV+ individuals.

  1996cites this paper
• Cognitive decline in patients with symptomatic HIV‐1 infection. No decline in asymptomatic infection

  1996cites this paper
• Primate lentivirus-associated encephalopathy

  1996cites this paper
• A Novel Approach to the Determination and Characterization of HIV Dementia

  1996cites this paper
• AIDS Dementia and HIV-1-Induced Neurotoxicity: Possible Pathogenic Associations and Mechanisms.

  1996cites this paper
• Delayed latency of the event-related brain potential P3A component in HIV disease. Progressive effects with increasing cognitive impairment.

  1995cites this paper
• Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.

  1995cites this paper
• Reaction time slowing in HIV-1-infected individuals: role of the preparatory interval.

  1995cites this paper
• The Use of Methylphenidate for Cognitive Decline Associated with HIV Disease

  1995cites this paper
• Quantification of Quinolinic Acid Metabolism by Macrophages and Astrocytes

  1995cites this paper
• Alcohol abuse and HIV infection have additive effects on frontal cortex function as measured by auditory evoked potential P3A latency.

  1995cites this paper
• Zidovudine treatment prolongs survival and decreases virus load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus.

  1995cites this paper
• Global–local Analysis in Hiv-1 Infection

  1995cites this paper
• Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-Type-1 infected individuals

  1995cites this paper
• A client-server technology solution for a multicenter research database

  1994cites this paper
• Visual attention in HIV-1 infection.

  1994cites this paper
• Working memory in individuals with HIV infection.

  1994cites this paper
• Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection.

  1994cites this paper
• Quinolinic acid in neurological disease: opportunities for novel drug discovery.

  1994cites this paper
• Human Immunodeficiency Virus Research Program

  1993cites this paper
• Lack of evidence for Huntington's disease-like cognitive dysfunction in obsessive-compulsive disorder.

  1993cites this paper
• AIDS and the Central Nervous System: Examining Pathobiology and Testing Therapeutic Strategies in the SIV‐Infected Rhesus Monkey a

  1993cites this paper
• Impaired motor-skill learning, slowed reaction time, and elevated cerebrospinal-fluid quinolinic acid in a subgroup of HIV-infected individuals.

  1993cites this paper
• Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response.

  1993cites this paper
• Neuro-AIDS: primate lentivirus infection and the brain

  1993cites this paper